A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
Clinical trial NCT00968981 · COMPLETED
Trial details
- NCT number
- NCT00968981
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.